The specific CD36 gene variant linked to DCM was found in 17% of those with African ancestry, but less than 0.1% of those with European ancestry, a difference that the researchers speculate may be due ...
CHARLOTTE, N.C. and STAMFORD, Conn., Oct. 20, 2025 (GLOBE NEWSWIRE) -- HCM II Acquisition Corp. (Nasdaq: HOND) (“HCM II”), a special-purpose acquisition company, is pleased to announce that in an ...
In this cross-sectional study including 1 825 patients with HCM, Chinese patients have a higher proportion of rare variants but have a similar proportion of likely pathogenic or pathogenic variants ...
Hypertrophic cardiomyopathy (HCM), a common genetic heart disorder, is often caused by mutations in sarcomere-related genes. While extensively studied in European populations, its genetic basis in ...
Arrhythmias, or irregular heart rhythms, are common complications of HCM. The thickened heart muscle disrupts the electrical pathways that coordinate heartbeat, leading to arrhythmias. Atrial ...
The Health Information Sharing and Analysis Center, a nonprofit organization that works to share threat intelligence, issued an alert Oct. 1 regarding LockBit 5.0, a ransomware variant that represents ...
A new COVID-19 variant — XFG, also known as Stratus — is spreading rapidly, the Centers for Disease Control and Prevention says. The South Carolina Department of Health does not track COVID infection ...
Oracle yesterday announced more than a dozen AI agents that will be available as part of its Fusion HCM application, complementing the twelve already announced earlier this year, along with many ...
Researchers have discovered the first genetic mutation associated with hypertrophic cardiomyopathy (HCM) and sudden death in golden retrievers. The work could lead to increased early detection and ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. “Man’s best friend” is proving to be helpful for studying a ...
Hypertrophic cardiomyopathy (HCM) is a common, often inherited, and complex cardiac disease that can result in a high symptom burden. The principles of HCM management include familial cascade ...
Mavacamten is approved to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). However, its effects in nonobstructive HCM remain uncertain. We conducted a phase 3, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback